Management

ROBERT L. CHIOINI

Chief Executive Officer

Robert L. Chioini, 56, is the Chief Executive Officer of SQI Diagnostics, Inc. and has served in that position since August 2020. Prior to joining SQI, Mr. Chioini was the Founder, Chairman and Chief Executive Officer of Rockwell Medical, Inc. (NASDAQ: RMTI) from January 1995 to May 2018, where he built the business from inception into a vertically integrated publicly traded $950 million pharmaceutical drug and medical device company servicing the U.S. and global dialysis healthcare market. Mr. Chioini was a recipient of 40 Under 40 Crain’s Detroit Business in 2001, the winner of Ernst & Young Entrepreneur of Year Michigan Great Lakes Region in 2005 and from 2000-2018 served as a Board Member of Medical Main Street, an alliance of world-class hospitals, universities, medical device and biopharmaceutical companies creating a global center of innovation in health care, research and development, education and commercialization in the life sciences industry in Oakland County, Michigan. From 1987 to 1995, Mr. Chioini was a sales executive at medical manufacturing companies Tri-State Hospital Supply Corp. and Dial Medical, Inc. (acquired by Gambro Healthcare, Inc.), operating in the hospital supply and dialysis markets respectively. Mr. Chioini is a graduate of Michigan State University and earned his Bachelor of Arts degree in Advertising from the College of Communication Arts and Sciences in 1987.

ERIC BROUWER, PHD

Chief Scientific Officer

Eric Brouwer, PhD, 53, is the Chief Scientific Officer of SQI Diagnostics, Inc. and has served in that position since October 2017. From April 2015 to May 2017, Mr. Brouwer was the Chief Scientific Officer of Trinity Biotech plc and then CEO of its subsidiary, Fiomi. From 2003 to 2015, Mr. Brouwer held various positions in Research and Development at Abbott Point of Care, including Senior Manager Research and Director of Assay Research and Development. While at Abbott, Mr. Brouwer developed and help launch a number of point of care diagnostics products, was the recipient of two divisional President’s Awards (2006, 2008) and the prestigious Chairman’s Award in 2007 and served as a member of the Abbott Scientific Governing Board. Mr. Brouwer also was a member of the Ottawa Life Sciences Council 2013 to 2014. From 2000 to 2003, Mr. Brouwer was a Senior Scientist at the point-of-care diagnostic innovator and industry leader i-STAT, prior to the acquisition of i-STAT by Abbott. Mr. Brouwer holds three U.S. patents and has authored over 30 peer-reviewed journal articles. Mr. Brouwer holds multiple degrees in chemistry from Queen’s University (BSc(Hons)), University of British Columbia (MSc) and Carleton University (PhD) and a post-doctoral fellowship at the University of Durham (UK).

Morlan Reddock

Chief Financial Officer

Morlan Reddock, 51, is the Chief Financial Officer of SQI Diagnostics, Inc. and has served in that position since March 2020. From July 2017 to October 2019, Mr. Reddock served as the Director of Finance for the Greater Toronto Airports Authority (GTAA) and from December 2017 to October 2019 served concurrently as Acting CFO for the GTAA subsidiary Malton Gateway. From May 2016 to July 2017, Mr. Reddock served as the Vice President Finance for Ronnex Distribution. From 2008 to 2015 Mr. Reddock was the Director of Finance, Treasury and Investor Relations for SiriusXM Canada. From 2005 to 2008, Mr. Reddock was Manager of Finance, Acquisitions and Planning for Direct Energy. From 1999 to 2005, Mr. Reddock held positions in Accounting and Finance. Mr. Reddock is a member of the Chartered Professional Accountants of Ontario, The CFO Leadership Council (Toronto Chapter) and Financial Executives International (FEI). Mr. Reddock is a CPA, CFA, and holds an MBA from the Rotman School of Management, a Bachelor of Engineering degree from Concordia University and has completed Executive Leadership training at the Ivey School of Business.

RUSSELL PELOQUIN

Vice President, Global Commercial Operations

Russell A. Peloquin, 41, is Vice President, Global Commercial Operations at SQI Diagnostics, Inc. and has served in that position since May 2012. Mr. Peloquin oversees sales, marketing, business development, customer solutions, field technical support and partner relations. From 2010-2012, Mr. Peloquin was the Director of Sales and Marketing for NorDiag Inc., a Sweden-based biotechnology company focused on nucleic acid extraction technologies within the field of molecular diagnostics. From 2008-2010, Mr. Peloquin oversaw one of the clinical diagnostic business units of Luminex Corp., the world leader in multiplexed assay technology where he led teams to successfully create the market for and launch several molecular diagnostic assay products and automation systems. From 2003-2008, Mr. Peloquin held several roles and responsibilities at Quest Diagnostics, Inc., the world’s largest clinical reference laboratory where his responsibilities included contract negotiations, new laboratory technology evaluation, sales and logistics management, and experience in M&A. Mr. Peloquin graduated from the University of Kansas with a Bachelor’s of Science degree in Advertising and Marketing from the William Allen White School of Journalism.